Researchers at the Johns Hopkins Kimmel Cancer Center have sequenced DNA from patients with an uncommon form of pancreatic cancer to produce the first overview of the genetic basis of the disease, called neuroendocrine tumors. The investigators identified several genes that may provide prognostic information, as well as mutations in genes in a signaling pathway for which targeted therapies currently exist. Read more > >
The two researchers from NCI’s Division of Cancer Control and Population Sciences spoke about a study published earlier this month in JNCI and how we may be able to address the looming issue of caring for a growing population of cancer survivors. Read more > >
- FDA Updates Safety Review of Diabetes Drug for Possible Cancer Risk
- In Memoriam: Arthur Schatzkin, Branch Chief in DCEG
- New Program Aims to Help Businesses Navigate Regulatory Clearance for Products
- New Issue of CCR Connections Published
- State Cancer Legislative Database Adds Obesity Prevention
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at email@example.com.